WH announces 9 new agreements with pharma manufacturers aimed at slashing prescription drug costs for Americans

0
132
US President Donald Trump shakes hands with Richard Ascroft, CEO North America of Sun Pharma, during an announcement on Healthcare Affordability in the Oval Office of the White House in Washington, DC on August 31, 2026. (Photo by Brendan SMIALOWSKI / AFP via Getty Images)

OAN Staff Brooke Mallory
5:40 PM – Monday, August 31, 2026

In a major policy milestone for healthcare reform, President Donald Trump announced nine new agreements with pharmaceutical manufacturers aimed at slashing prescription drug costs for Americans.

Under these voluntary deals, manufacturers agree to align U.S. drug pricing with the lowest prices paid by other developed countries, a framework known as the most-favored-nation (MFN) price model. The latest expansion brings the total roster of pharmaceutical companies participating in MFN pricing to 26, collectively representing roughly 89% of…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here